Many different oral antidiabetic drugs (OADs) combined with insulin have been approved for type 2 diabetes (T2DM), including metformin, incretin analogs, and sodium–glucose cotransporter (SGLT) 2 inhibitors (SGLT-2is) [10–12]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.